VolkerWilhelmStieberMD
Radiation Oncology • Winston Salem, NCCentral Nervous System Cancer, Thoracic Cancer
Physician
Dr. Stieber is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3333 Silas Creek Pkwy
Winston Salem, NC 27103Phone+1 336-718-5095Fax+1 336-718-9895
Summary
- Dr. Volker Stieber is a radiation oncologist in Winston Salem, NC and is affiliated with the Novant Health Cancer Institute at Forsyth Medical Center. He is the IRB Chair and the Neuro-Oncology Council Co-Chair. He specializes in central nervous system tumors, thoracic oncology, and radiotherapy for benign conditions.
Education & Training
Mayo Clinic College of Medicine1998 - 2000
Medical University of South CarolinaResidency, Radiation Oncology, 1995 - 1998
Loma Linda University Health Education ConsortiumInternship, Internal Medicine, 1994 - 1995
Loma Linda University School of MedicineClass of 1994
University of CaliforniaBA, Biology & English, 1984 - 1988
Certifications & Licensure
NC State Medical License 2000 - 2025
SC State Medical License 1996 - 2025
CA State Medical License 1997 - 2002
FL State Medical License 1998 - 2002
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2013
Clinical Trials
- Radiation Therapy Plus Thalidomide and Temozolomide in Treating Patients With Newly Diagnosed Brain Metastases Start of enrollment: 2004 Jan 01
- Surgery Followed by Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Start of enrollment: 2003 Oct 01
- Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma Start of enrollment: 2004 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Clinical and genetic markers of vascular toxicity in glioblastoma patients: Insights from NRG Oncology RTOG-0825.Joshua D Strauss, Mark R Gilbert, Minesh Mehta, Ang Li, Renke Zhou
Neuro-Oncology. 2025-03-07 - 4 citationsNRG/RTOG 0837: Randomized, phase II, double-blind, placebo-controlled trial of chemoradiation with or without cediranib in newly diagnosed glioblastoma.Tracy T Batchelor, Minhee Won, Arnab Chakravarti, Costas G Hadjipanayis, Wenyin Shi
Neuro-Oncology Advances. 2023-10-11 - 1 citationsGermline polymorphisms inassociated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825.Michael E Scheurer, Renke Zhou, Mark R Gilbert, Melissa L Bondy, Erik P Sulman
Neuro-Oncology Advances. 2022-10-22
Press Mentions
Dr. Volker W. Stieber, MD, Joins Vivacitas' Neuro-Oncology Advisory BoardFebruary 7th, 2022
Committees
- Leader, Novant Health Cancer Institute GWSM Neuro-Oncology Council 2019 - Present
- Chair, IRB, Novant Health Forsyth Medical Center
Professional Memberships
- Member
- Member
- Society for Neuro-Oncology (SNO)Member
Other Languages
- German
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
